thiophenes has been researched along with ve 821 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, EG; Fehrmann, RS; Franke, L; Krajewska, M; Labib, S; Schoonen, PM; van Vugt, MA | 1 |
| Ali, S; Buluwela, L; Farzan, R; Meek, DW; Saurin, AT; Smith, L | 1 |
2 other study(ies) available for thiophenes and ve 821
| Article | Year |
|---|---|
ATR inhibition preferentially targets homologous recombination-deficient tumor cells.
Topics: Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Cell Survival; Checkpoint Kinase 1; Drug Resistance, Neoplasm; HeLa Cells; Homologous Recombination; Humans; MCF-7 Cells; Molecular Targeted Therapy; Neoplasms; Protein Kinases; Pyrazines; Signal Transduction; Sulfones; Thiophenes; Urea | 2015 |
The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation.
Topics: Benzimidazoles; Cell Cycle Proteins; Cell Survival; Centrosome; Fluorescent Antibody Technique; Gene Silencing; HCT116 Cells; Humans; Mitosis; Morpholines; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pyrazines; Pyrones; Sulfones; Thiophenes; Tumor Suppressor Protein p53 | 2017 |